Quantinno Capital Management’s Astria Therapeutics ATXS Stock Holding History

Quantinno Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,724	Closed	-$363K	–	3306
2025 Q4	$363K	Buy	27,724 +1,410	+5%	+$16.8K	﹤0.01%	2704
2025 Q3	$192K	Buy	26,314 +8,922	+51%	+$60.4K	﹤0.01%	2775
2025 Q2	$93.2K	Buy	17,392 +771	+5%	+$3.74K	﹤0.01%	2519
2025 Q1	$88.8K	Buy	+16,621	New	+$116K	﹤0.01%	2047

Quantinno Capital Management's ATXS Position: Q1 2026 in Review

Quantinno Capital Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 27,724 shares — an estimated $363K sold.

Quantinno Capital Management first reported a position in ATXS in Q1 2025 and held it in 4 quarters. The position peaked at $363K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Quantinno Capital Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Quantinno Capital Management sold 27,724 Astria Therapeutics shares in Q1 2026, an estimated $363K.
Quantinno Capital Management first reported a position in Astria Therapeutics in Q1 2025 and held it in 4 quarters.
Quantinno Capital Management's Astria Therapeutics position peaked at $363K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.